Neurobo Pharmaceuticals Inc (NASDAQ:NRBO) shares are trading higher by 77.04% to $0.49 Monday morning after the company announced a 1-for-30 reverse stock split.
The number of authorized shares of the Company's common stock will remain at 100 million, while the number of outstanding shares will be reduced from approximately 26.7 million to approximately 0.9 million.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Beginning Tuesday, the Neurobo Pharmaceuticals' common stock will trade on The Nasdaq Capital Market on a split adjusted basis.
See Also: Why Akari Therapeutics Shares Are Getting Obliterated
According to data from Benzinga Pro, Neurobo Pharmaceuticals has a 52-week high of $4.29 and a 52-week low of $0.25.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.